Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Garon

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Vaccine|February 19, 2022
Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohortsAnna Hidle, Timothy Brennan, Julie Garon, et al.
Vaccine|October 1, 2021
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learnedRebecca M Casey, Nedghie Adrien, Ousseynou Badiane, et al.
Fundamental & Clinical Pharmacology|October 12, 2018
Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance databaseJulie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Scientific Reports|December 21, 2019
Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance databaseJulie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Autoimmunity Reviews|November 16, 2020
Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approachCamille Rasmussen, Mylène Tisseyre, Julie Garon-Czmil, et al.
The Journal of Infectious Diseases|August 26, 2017
Disposing of Excess Vaccines After the Withdrawal of Oral Polio VaccineSarah Wanyoike, Alejandro Ramirez Gonzalez, Samantha B Dolan, et al.
The Journal of Infectious Diseases|August 26, 2017
Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine GloballySamantha B Dolan, Manish Patel, Lee M Hampton, et al.
PLOS Global Public Health|March 24, 2023
Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020Reena H Doshi, Rebecca M Casey, Nedghie Adrien, et al.
The Journal of Infectious Diseases|August 26, 2017
Monitoring and Validation of the Global Replacement of tOPV with bOPV, April-May 2016Margaret Farrell, Lee M Hampton, Stephanie Shendale, et al.
MMWR. Morbidity and Mortality Weekly Report|September 9, 2016
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016Lee M Hampton, Margaret Farrell, Alejandro Ramirez-Gonzalez, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Vaccine|February 19, 2022
Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohortsAnna Hidle, Timothy Brennan, Julie Garon, et al.
Vaccine|October 1, 2021
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learnedRebecca M Casey, Nedghie Adrien, Ousseynou Badiane, et al.
Fundamental & Clinical Pharmacology|October 12, 2018
Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance databaseJulie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Scientific Reports|December 21, 2019
Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance databaseJulie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Autoimmunity Reviews|November 16, 2020
Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approachCamille Rasmussen, Mylène Tisseyre, Julie Garon-Czmil, et al.
The Journal of Infectious Diseases|August 26, 2017
Disposing of Excess Vaccines After the Withdrawal of Oral Polio VaccineSarah Wanyoike, Alejandro Ramirez Gonzalez, Samantha B Dolan, et al.
The Journal of Infectious Diseases|August 26, 2017
Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine GloballySamantha B Dolan, Manish Patel, Lee M Hampton, et al.
PLOS Global Public Health|March 24, 2023
Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020Reena H Doshi, Rebecca M Casey, Nedghie Adrien, et al.
The Journal of Infectious Diseases|August 26, 2017
Monitoring and Validation of the Global Replacement of tOPV with bOPV, April-May 2016Margaret Farrell, Lee M Hampton, Stephanie Shendale, et al.
MMWR. Morbidity and Mortality Weekly Report|September 9, 2016
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016Lee M Hampton, Margaret Farrell, Alejandro Ramirez-Gonzalez, et al.
Pageof 3